Industry

ISO 13485 Clause 5: Management Responsibility

Equip IgeraSolutions
September 25, 2026
9 min read
ISO 13485 Clause 5: Management Responsibility
🎧 Listen with AI Voice

2-minute executive summary

⚡ Quick Answer in 30s

ISO 13485 Clause 5 explained: quality policy, objectives, management review, and why a named Management Representative is non-negotiable.

✓ Citing current regulationsSee detailed guide below ↓

ISO 13485 · Medical devices QMS series

ISO 13485 Clause 5: Management Responsibility

Clause 5 of ISO 13485:2016 sets out what top management must actually do to run a medical device quality management system — not just approve it from a distance. It covers management commitment, a documented quality policy, measurable quality objectives, defined responsibility and authority, and periodic management review. The clause that trips up organizations migrating from ISO 9001 is 5.5.2: top management must appoint a specific member of management — commonly called the Management Representative — with defined responsibility and authority for the QMS, a role ISO 13485 spells out more explicitly than ISO 9001 does. This guide walks through what Clause 5 requires, why that role matters in practice, and the findings auditors raise most often.

A quick citable answer

ISO 13485:2016 Clause 5 requires top management to demonstrate commitment to the QMS, establish a documented quality policy and measurable objectives, define and communicate responsibilities, and conduct management reviews at planned intervals. Unlike ISO 9001, Clause 5.5.2 requires top management to appoint a named member of management with explicit, documented responsibility and authority for the QMS — a role widely referred to in practice as the Management Representative, even though the 2016 revision no longer uses that exact title in the clause heading.

Structure of Clause 5

Clause 5 (Management Responsibility) sits inside ISO 13485's quality management system requirements and is organized into six subclauses:

  • 5.1 Management commitment: top management must provide evidence of its commitment to developing, implementing, and maintaining the QMS and its effectiveness.
  • 5.2 Customer focus: top management must ensure customer requirements and applicable regulatory requirements are determined and met.
  • 5.3 Quality policy: a documented policy appropriate to the organization's purpose, including commitment to comply with requirements and maintain QMS effectiveness.
  • 5.4 Planning: establishing quality objectives (5.4.1) and QMS planning to meet those objectives and the general requirements of the standard (5.4.2).
  • 5.5 Responsibility, authority and communication: defining responsibility and authority (5.5.1), appointing a management representative (5.5.2), and ensuring internal communication (5.5.3).
  • 5.6 Management review: general requirements (5.6.1), review input (5.6.2), and review output (5.6.3).

5.1–5.2: Commitment and customer focus

Clause 5.1 requires top management to provide evidence of commitment through communicating the importance of meeting customer and regulatory requirements, establishing the quality policy and objectives, conducting management reviews, and ensuring the availability of resources. This is deliberately broad — the standard wants proof of active involvement, not a signed policy filed away and forgotten.

Clause 5.2 ties this commitment directly to customer focus: top management must ensure that customer requirements and applicable regulatory requirements are determined and met. In a medical device context, "regulatory requirements" is doing real work in that sentence — it covers the device's intended markets, not just the customer's stated preferences, and links Clause 5 to the regulatory determination obligations found elsewhere in the standard.

5.3–5.4: Quality policy and objectives

The quality policy required by 5.3 must be appropriate to the purpose of the organization, include a commitment to comply with requirements and maintain the effectiveness of the QMS, provide a framework for establishing and reviewing quality objectives, be communicated and understood within the organization, and be reviewed for continuing suitability. It is not a marketing statement — auditors expect staff to be able to explain, in their own words, what the policy means for their day-to-day work.

Clause 5.4.1 requires quality objectives, including those needed to meet product requirements, to be established at relevant functions and levels within the organization. Objectives must be measurable and consistent with the quality policy. Clause 5.4.2 then requires planning to ensure the QMS meets both the general requirements of the standard and these objectives, and — importantly — requires that the integrity of the QMS is maintained when changes to it are planned and implemented.

5.5.1–5.5.3: Responsibility, authority, and the Management Representative

Clause 5.5.1 requires top management to ensure that responsibilities and authorities are defined, documented, and communicated within the organization. So far, this reads similarly to the equivalent requirement in ISO 9001.

Clause 5.5.2 is where ISO 13485 diverges in a way that matters operationally. It requires top management to appoint a member of the organization's management who, irrespective of other responsibilities, has defined responsibility and authority that includes: ensuring processes needed for the QMS are documented; reporting to top management on the effectiveness of the QMS and on any need for improvement; and ensuring the promotion of awareness of applicable regulatory requirements and QMS requirements throughout the organization. This individual is widely referred to in industry practice as the Management Representative, a title that ISO 13485 used explicitly in its 2003 edition and that persists in common usage even though the 2016 text describes the role by function rather than by that exact label in the clause itself.

Why this differs from ISO 9001

ISO 9001:2015 removed the standalone requirement for a formally appointed "management representative" as a fixed role, allowing organizations to assign the equivalent responsibilities and authorities across roles more flexibly — for example, distributed among several people or embedded in existing job descriptions, without requiring one individual to hold the title. ISO 13485:2016 kept the explicit requirement for one named person with these defined QMS responsibilities. For a device manufacturer, this means you cannot simply spread QMS oversight duties across a management team and call it compliant — you need someone appointable and identifiable as holding this specific mandate, even if the standard no longer prints the words "management representative" in the clause text itself.

Clause 5.5.3 requires top management to ensure appropriate communication processes are established within the organization, and that communication takes place regarding the effectiveness of the QMS. In practice, this is usually evidenced through management review minutes, internal quality bulletins, or documented briefings following audits or CAPA closures.

5.6: Management review

Clause 5.6.1 requires top management to review the organization's QMS at planned intervals to ensure its continuing suitability, adequacy, and effectiveness, and to include an assessment of opportunities for improvement and the need for changes, including to the quality policy and objectives. Records of these reviews must be maintained.

Clause 5.6.2 specifies the inputs that must feed into the review — at minimum, feedback, complaint handling, reporting to regulatory authorities, audits, monitoring and measurement of processes and product, corrective and preventive actions, follow-up actions from previous reviews, changes that could affect the QMS, and recommendations for improvement. Clause 5.6.3 specifies the outputs: decisions and actions related to improvement needed to maintain the suitability, adequacy, and effectiveness of the QMS and its processes; improvement of product related to customer requirements; and resource needs.

Subclause Core requirement Typical evidence
5.1 Management commitment to the QMS Resourcing decisions, review attendance, communications
5.3 Documented, communicated quality policy Policy document, staff awareness evidence
5.4.1 Measurable quality objectives at relevant functions Objective-setting records, KPI tracking
5.5.2 Named Management Representative appointed Appointment letter, job description, org chart
5.6.1–5.6.3 Management review at planned intervals Review minutes with defined inputs and outputs

Practical implications for device manufacturers

The appointment requirement in 5.5.2 is not paperwork for its own sake. Notified bodies and regulatory auditors use it as an anchor point: when they want to understand how a nonconformity was escalated, how a regulatory reporting decision was made, or who is accountable for QMS effectiveness between management reviews, they expect to be pointed to this named individual. Smaller manufacturers sometimes assign the role to the quality manager by default without documenting the specific authorities listed in 5.5.2 — that gap between "does the job" and "is formally appointed with defined authority" is exactly what auditors probe.

Management review is the other area where organizations underinvest. A review that happens on schedule but skips required inputs — say, it covers audit results but not complaint trends or regulatory reporting — technically satisfies 5.6.1's timing requirement while failing 5.6.2's content requirement. Keeping a standing agenda that maps directly to the 5.6.2 input list is the simplest way to avoid this.

Common mistakes

  • No formal appointment record for the Management Representative role: the person performs the function informally, but there is no documented appointment defining the specific 5.5.2 responsibilities and authority.
  • Quality objectives that are not measurable: vague statements with no indicator or target, making 5.4.1 conformity impossible to demonstrate.
  • Management review missing required inputs: reviews that cover only a subset of the 5.6.2 inputs, commonly omitting regulatory reporting or follow-up on actions from prior reviews.
  • Policy known to management but not understood by staff: 5.3 requires the policy to be communicated and understood, not merely published.
  • Review outputs not tracked to closure: decisions recorded in review minutes but never linked to a resourced action with an owner and due date.

This is also where a tool like IgeraIndustria fits naturally into a QMS: when an auditor or a newly appointed Management Representative asks "what did the last three management reviews decide about complaint trends," a system that answers directly from your own QMS records — appointment letters, review minutes, objective trackers — and cites the exact source document is faster and more defensible than searching through shared drives for the right version.

Frequently asked questions about ISO 13485 Clause 5

Does ISO 13485 still use the term "Management Representative"?

The 2016 edition of ISO 13485 describes the role by its responsibilities in Clause 5.5.2 rather than using "Management Representative" as a formal clause heading, but the role is functionally the same one that carried that title in the 2003 edition, and the term remains in common industry and auditor use to describe the appointed individual.

How is this different from ISO 9001's approach to management responsibility?

ISO 9001:2015 allows organizations to distribute the equivalent responsibilities and authorities across roles without requiring a single formally appointed representative. ISO 13485:2016 keeps the explicit requirement in 5.5.2 for top management to appoint one specific member of management with defined responsibility and authority for the QMS, making the role more clearly mandated than under ISO 9001.

Can the Management Representative also hold another role, such as quality manager?

Clause 5.5.2 states the appointment is "irrespective of other responsibilities," which means the role can be combined with another position such as quality manager. What matters is that the specific responsibilities and authority described in 5.5.2 are formally documented and assigned to that individual, not that the role stands alone on an org chart.

What must be covered in a management review under Clause 5.6?

Clause 5.6.2 lists the required inputs, including feedback, complaint handling, reporting to regulatory authorities, audit results, process and product monitoring data, corrective and preventive actions, follow-up from previous reviews, changes affecting the QMS, and improvement recommendations. Clause 5.6.3 requires the review to produce outputs covering QMS and process improvement, product improvement related to customer requirements, and resource needs.

How often must management review take place?

Clause 5.6.1 requires review "at planned intervals" without specifying a fixed frequency, so the organization must define and justify its own interval and demonstrate it is actually followed. Many manufacturers run reviews annually with more frequent interim reviews, but the specific cadence should be documented in the QMS rather than assumed.

What evidence do auditors typically ask for under Clause 5?

Common requests include the appointment record and job description for the Management Representative, the current quality policy with evidence of staff awareness, quality objectives with tracked performance, and management review minutes showing the required inputs were discussed and that outputs were assigned to owners with due dates.

Is a small manufacturer exempt from appointing a Management Representative?

No. Clause 5.5.2 applies regardless of organization size, though in a small company the role is often combined with another position, such as the quality manager or even the general manager, as permitted by the "irrespective of other responsibilities" wording. The size of the organization does not remove the requirement to formally document the appointment and its specific authorities.

Disclaimer: This article is informational and does not constitute certification, legal, or regulatory advice, and it is not a substitute for the full text of ISO 13485:2016. Requirements, their interpretation, and applicable regulatory context can vary by market and change over time. Before making compliance decisions, consult a qualified quality/regulatory consultant or your notified body.

Need fast, traceable answers from your QMS documentation?

IgeraIndustria answers directly from your own QMS documents — appointment records, policy, review minutes — and cites the exact source, so your Management Representative and your auditors get the same answer, every time.

View ISO 13485 solution

IgeraSolutions · ISO 13485 medical devices QMS series

#iso 13485 clause 5#iso 13485 management responsibility#management representative iso 13485#iso 13485 vs iso 9001#iso 13485 management review#quality policy iso 13485#iso 13485 quality objectives#iso 13485 5.5.2

Ask this article

IA 2026

Igera's AI answers questions citing the facts and regulations in this article

2 of 2 free queries

Suggested questions (click to test):

Diagnóstico Interactivo 60s

Technical Compliance & Industrial Operations Diagnostic

Analyze speed of access to regulations (CTE, OSH, CE) in your plant or jobsite

Pregunta 1 de 3

How do technicians and operators access safety protocols and manuals?

Was this article helpful?

⚙️IgeraIndustriaOperations Template
GUÍA DESCARGABLE (TXT)

Preventive Maintenance & ISO 9001/45001 Industrial Checklist

Floor inspection template for machine operations, failure tracking and unplanned downtime reduction.

  • Shift inspection standardization for plant operators
  • Up to 40% faster anomaly response times
  • Full traceability for ISO audits and HSE compliance

Instant download · No card · 100% spam-free

Share this article

Help spread knowledge by sharing this content with your network